TORONTO, May 27 /CNW/ - Microbix Biosystems Inc. (TSX:MBX) has been
granted a patent by the State Intellectual Property Office of the People's
Republic of China for its VIRUSMAX(TM) technology which enables egg-based
vaccine manufacturers to significantly increase the amount of influenza
vaccine they produce each year.
